| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Multiple Sclerosis | 25 | 2024 | 3079 | 5.360 |
Why?
|
| Neurology | 20 | 2023 | 763 | 4.940 |
Why?
|
| Nervous System Diseases | 20 | 2023 | 1622 | 4.290 |
Why?
|
| Neuromyelitis Optica | 8 | 2023 | 252 | 3.850 |
Why?
|
| Epilepsy | 27 | 2024 | 3310 | 3.630 |
Why?
|
| Refugees | 10 | 2022 | 511 | 3.170 |
Why?
|
| Encephalomyelitis, Acute Disseminated | 6 | 2021 | 66 | 2.910 |
Why?
|
| Developing Countries | 19 | 2022 | 2815 | 2.800 |
Why?
|
| Demyelinating Diseases | 4 | 2023 | 354 | 2.690 |
Why?
|
| Altruism | 6 | 2019 | 204 | 2.040 |
Why?
|
| Internationality | 7 | 2021 | 1003 | 1.830 |
Why?
|
| Stroke | 17 | 2022 | 9981 | 1.640 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 4 | 2021 | 134 | 1.590 |
Why?
|
| Guinea | 12 | 2024 | 41 | 1.460 |
Why?
|
| Tissue Plasminogen Activator | 5 | 2018 | 1261 | 1.430 |
Why?
|
| World Health Organization | 5 | 2021 | 1318 | 1.350 |
Why?
|
| Fluoxetine | 3 | 2021 | 749 | 1.290 |
Why?
|
| Bhutan | 12 | 2020 | 60 | 1.260 |
Why?
|
| Financial Management | 2 | 2022 | 160 | 1.180 |
Why?
|
| Income | 6 | 2022 | 1913 | 1.140 |
Why?
|
| Seizures | 8 | 2024 | 2859 | 1.120 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 3 | 2022 | 518 | 1.100 |
Why?
|
| Brain Ischemia | 8 | 2020 | 3265 | 1.060 |
Why?
|
| Education, Medical | 6 | 2018 | 1721 | 1.040 |
Why?
|
| Humans | 197 | 2024 | 744343 | 1.010 |
Why?
|
| Educational Status | 5 | 2024 | 2540 | 0.990 |
Why?
|
| Social Stigma | 5 | 2021 | 701 | 0.920 |
Why?
|
| Paralysis | 3 | 2013 | 247 | 0.900 |
Why?
|
| Familial Mediterranean Fever | 1 | 2023 | 61 | 0.880 |
Why?
|
| Adult | 88 | 2024 | 214055 | 0.870 |
Why?
|
| Immunologic Factors | 4 | 2022 | 1580 | 0.860 |
Why?
|
| Anticonvulsants | 6 | 2020 | 1916 | 0.850 |
Why?
|
| HIV Seronegativity | 2 | 2013 | 211 | 0.830 |
Why?
|
| Poverty | 7 | 2024 | 2660 | 0.830 |
Why?
|
| Population Surveillance | 4 | 2021 | 2616 | 0.820 |
Why?
|
| Female | 111 | 2024 | 380194 | 0.810 |
Why?
|
| Health Services Accessibility | 8 | 2019 | 5137 | 0.780 |
Why?
|
| Middle Aged | 79 | 2023 | 213383 | 0.780 |
Why?
|
| Depression | 8 | 2023 | 7766 | 0.770 |
Why?
|
| Meningitis, Meningococcal | 1 | 2021 | 43 | 0.770 |
Why?
|
| Clarithromycin | 1 | 2021 | 86 | 0.760 |
Why?
|
| Central Nervous System Diseases | 3 | 2021 | 518 | 0.750 |
Why?
|
| Male | 102 | 2024 | 350118 | 0.750 |
Why?
|
| Tanzania | 6 | 2022 | 1346 | 0.720 |
Why?
|
| Academies and Institutes | 2 | 2015 | 317 | 0.690 |
Why?
|
| Ophthalmoplegia, Chronic Progressive External | 1 | 2018 | 17 | 0.680 |
Why?
|
| Cognition Disorders | 6 | 2018 | 4043 | 0.650 |
Why?
|
| Relief Work | 1 | 2020 | 137 | 0.650 |
Why?
|
| Susac Syndrome | 2 | 2023 | 22 | 0.640 |
Why?
|
| Hallucinations | 1 | 2021 | 360 | 0.640 |
Why?
|
| Rural Population | 8 | 2019 | 2210 | 0.640 |
Why?
|
| Fasciculation | 2 | 2008 | 8 | 0.640 |
Why?
|
| Central Nervous System Infections | 3 | 2014 | 56 | 0.640 |
Why?
|
| HIV Infections | 10 | 2021 | 16718 | 0.630 |
Why?
|
| Arsenic | 2 | 2020 | 328 | 0.630 |
Why?
|
| Phototherapy | 2 | 2020 | 377 | 0.630 |
Why?
|
| Curriculum | 5 | 2023 | 3605 | 0.620 |
Why?
|
| Areca | 1 | 2017 | 11 | 0.620 |
Why?
|
| Aged | 62 | 2023 | 163280 | 0.620 |
Why?
|
| Paresthesia | 2 | 2009 | 161 | 0.620 |
Why?
|
| Young Adult | 35 | 2023 | 56430 | 0.600 |
Why?
|
| Neck Pain | 2 | 2009 | 180 | 0.600 |
Why?
|
| Cost of Illness | 3 | 2020 | 1859 | 0.600 |
Why?
|
| Splenectomy | 1 | 2019 | 395 | 0.600 |
Why?
|
| HIV Seropositivity | 2 | 2013 | 971 | 0.590 |
Why?
|
| Mastication | 1 | 2017 | 53 | 0.590 |
Why?
|
| Brain | 15 | 2021 | 26385 | 0.590 |
Why?
|
| Anecdotes as Topic | 3 | 2005 | 57 | 0.590 |
Why?
|
| Encephalitis | 1 | 2021 | 423 | 0.590 |
Why?
|
| Health Services Needs and Demand | 6 | 2019 | 1411 | 0.570 |
Why?
|
| Delivery of Health Care | 4 | 2020 | 5319 | 0.570 |
Why?
|
| Career Choice | 3 | 2015 | 744 | 0.570 |
Why?
|
| Stereotyping | 2 | 2016 | 241 | 0.560 |
Why?
|
| Aquaporin 4 | 3 | 2022 | 153 | 0.560 |
Why?
|
| Health Personnel | 4 | 2023 | 3218 | 0.560 |
Why?
|
| Brain Death | 3 | 2015 | 348 | 0.550 |
Why?
|
| Diphtheria | 2 | 2013 | 35 | 0.550 |
Why?
|
| Charities | 1 | 2016 | 31 | 0.550 |
Why?
|
| Walking | 2 | 2021 | 1180 | 0.540 |
Why?
|
| Adolescent | 36 | 2023 | 85781 | 0.540 |
Why?
|
| Health Resources | 4 | 2019 | 911 | 0.540 |
Why?
|
| Amyotrophic Lateral Sclerosis | 4 | 2017 | 1414 | 0.540 |
Why?
|
| Muscle Weakness | 2 | 2009 | 413 | 0.530 |
Why?
|
| Costs and Cost Analysis | 1 | 2021 | 1681 | 0.530 |
Why?
|
| Herpesvirus 2, Human | 2 | 2014 | 189 | 0.530 |
Why?
|
| United Nations | 4 | 2022 | 165 | 0.520 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2015 | 63 | 0.520 |
Why?
|
| Recovery of Function | 3 | 2021 | 2925 | 0.520 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2020 | 3923 | 0.520 |
Why?
|
| Aged, 80 and over | 30 | 2021 | 57776 | 0.510 |
Why?
|
| Jordan | 4 | 2020 | 74 | 0.510 |
Why?
|
| Quality of Life | 7 | 2021 | 12804 | 0.510 |
Why?
|
| Electroencephalography | 9 | 2023 | 6150 | 0.500 |
Why?
|
| Motor Activity | 2 | 2019 | 2714 | 0.500 |
Why?
|
| Disasters | 2 | 2011 | 511 | 0.500 |
Why?
|
| Peripheral Nervous System Diseases | 2 | 2011 | 685 | 0.500 |
Why?
|
| Tropical Medicine | 1 | 2015 | 49 | 0.500 |
Why?
|
| Mandatory Programs | 1 | 2015 | 87 | 0.490 |
Why?
|
| Fatigue | 3 | 2020 | 1531 | 0.490 |
Why?
|
| Neglected Diseases | 1 | 2015 | 64 | 0.490 |
Why?
|
| Referral and Consultation | 3 | 2019 | 3528 | 0.480 |
Why?
|
| Magnetic Resonance Imaging | 20 | 2021 | 35421 | 0.480 |
Why?
|
| Fibrinolytic Agents | 4 | 2019 | 2158 | 0.470 |
Why?
|
| Influenza Vaccines | 1 | 2021 | 738 | 0.470 |
Why?
|
| Peripheral Nervous System | 1 | 2015 | 150 | 0.460 |
Why?
|
| Encephalitis, Herpes Simplex | 1 | 2014 | 60 | 0.460 |
Why?
|
| JC Virus | 3 | 2021 | 85 | 0.460 |
Why?
|
| Retrospective Studies | 31 | 2024 | 77449 | 0.450 |
Why?
|
| Corynebacterium diphtheriae | 1 | 2013 | 22 | 0.450 |
Why?
|
| Canada | 7 | 2020 | 2065 | 0.450 |
Why?
|
| Spinal Cord | 3 | 2017 | 1809 | 0.440 |
Why?
|
| Electromyography | 2 | 2008 | 1379 | 0.440 |
Why?
|
| Medication Adherence | 2 | 2021 | 2063 | 0.440 |
Why?
|
| Health Policy | 3 | 2023 | 2661 | 0.430 |
Why?
|
| Cause of Death | 5 | 2021 | 3584 | 0.430 |
Why?
|
| International Agencies | 1 | 2013 | 240 | 0.430 |
Why?
|
| Poliovirus Vaccine, Oral | 1 | 2012 | 28 | 0.430 |
Why?
|
| Meningitis, Viral | 2 | 2013 | 50 | 0.430 |
Why?
|
| Plasmapheresis | 2 | 2021 | 211 | 0.430 |
Why?
|
| Medical Oncology | 2 | 2020 | 2265 | 0.430 |
Why?
|
| Organizational Policy | 1 | 2015 | 429 | 0.430 |
Why?
|
| Immune Reconstitution Inflammatory Syndrome | 1 | 2012 | 66 | 0.420 |
Why?
|
| Spinal Cord Ischemia | 2 | 2010 | 93 | 0.420 |
Why?
|
| Brain Injuries | 3 | 2018 | 2025 | 0.420 |
Why?
|
| AIDS-Related Opportunistic Infections | 2 | 2012 | 657 | 0.410 |
Why?
|
| AIDS Dementia Complex | 1 | 2012 | 154 | 0.410 |
Why?
|
| Headache | 3 | 2008 | 1226 | 0.400 |
Why?
|
| Body Height | 1 | 2018 | 1577 | 0.400 |
Why?
|
| School Health Services | 1 | 2015 | 375 | 0.400 |
Why?
|
| Brain Diseases | 2 | 2011 | 1563 | 0.400 |
Why?
|
| Polyneuropathies | 1 | 2013 | 137 | 0.400 |
Why?
|
| Neoplasms | 6 | 2022 | 21683 | 0.390 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2021 | 1790 | 0.390 |
Why?
|
| Africa | 4 | 2015 | 673 | 0.390 |
Why?
|
| Plasma Exchange | 2 | 2012 | 152 | 0.390 |
Why?
|
| Catha | 1 | 2010 | 9 | 0.390 |
Why?
|
| Social Support | 6 | 2022 | 2118 | 0.390 |
Why?
|
| Schools, Medical | 1 | 2018 | 880 | 0.390 |
Why?
|
| Autoimmunity | 1 | 2019 | 1349 | 0.380 |
Why?
|
| Education, Medical, Graduate | 2 | 2016 | 2291 | 0.380 |
Why?
|
| Practice Guidelines as Topic | 3 | 2021 | 7279 | 0.380 |
Why?
|
| Physician's Role | 3 | 2007 | 943 | 0.380 |
Why?
|
| Treatment Outcome | 19 | 2022 | 63114 | 0.380 |
Why?
|
| Carotid Artery Diseases | 1 | 2017 | 882 | 0.380 |
Why?
|
| Persistent Vegetative State | 1 | 2013 | 260 | 0.370 |
Why?
|
| Neuroaxonal Dystrophies | 1 | 2010 | 22 | 0.370 |
Why?
|
| Thrombolytic Therapy | 2 | 2018 | 2161 | 0.370 |
Why?
|
| Health Expenditures | 3 | 2020 | 2348 | 0.370 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2011 | 120 | 0.360 |
Why?
|
| Death, Sudden | 1 | 2012 | 302 | 0.360 |
Why?
|
| Reproductive Medicine | 1 | 2011 | 108 | 0.350 |
Why?
|
| Registries | 4 | 2019 | 8089 | 0.350 |
Why?
|
| Wernicke Encephalopathy | 1 | 2009 | 28 | 0.350 |
Why?
|
| Cardiopulmonary Resuscitation | 2 | 2015 | 980 | 0.350 |
Why?
|
| Indians, North American | 2 | 2017 | 355 | 0.350 |
Why?
|
| Child | 25 | 2023 | 77709 | 0.350 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2021 | 4420 | 0.350 |
Why?
|
| Exodeoxyribonucleases | 1 | 2010 | 180 | 0.340 |
Why?
|
| Patients | 1 | 2016 | 900 | 0.340 |
Why?
|
| Education, Medical, Undergraduate | 3 | 2008 | 1008 | 0.340 |
Why?
|
| Biomedical Research | 2 | 2019 | 3309 | 0.340 |
Why?
|
| Transplants | 1 | 2011 | 209 | 0.340 |
Why?
|
| Stereotyped Behavior | 1 | 2009 | 136 | 0.330 |
Why?
|
| Autoantibodies | 3 | 2022 | 2035 | 0.330 |
Why?
|
| Vertebral Artery Dissection | 1 | 2009 | 48 | 0.330 |
Why?
|
| Earthquakes | 1 | 2011 | 179 | 0.330 |
Why?
|
| Needlestick Injuries | 1 | 2008 | 67 | 0.330 |
Why?
|
| Ethics, Medical | 2 | 2011 | 792 | 0.330 |
Why?
|
| Compulsive Behavior | 1 | 2009 | 117 | 0.320 |
Why?
|
| Human Rights | 1 | 2011 | 307 | 0.320 |
Why?
|
| Health Education | 1 | 2015 | 1056 | 0.320 |
Why?
|
| Autopsy | 1 | 2012 | 1020 | 0.310 |
Why?
|
| Neurologic Examination | 4 | 2015 | 930 | 0.310 |
Why?
|
| Neuroanatomy | 1 | 2008 | 66 | 0.310 |
Why?
|
| Basal Ganglia Diseases | 1 | 2008 | 149 | 0.310 |
Why?
|
| Emergencies | 2 | 2014 | 1170 | 0.310 |
Why?
|
| Iraq | 3 | 2012 | 92 | 0.310 |
Why?
|
| Hypoglossal Nerve Diseases | 1 | 2007 | 8 | 0.310 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2009 | 114 | 0.310 |
Why?
|
| Child, Preschool | 15 | 2019 | 41006 | 0.300 |
Why?
|
| Syria | 2 | 2020 | 76 | 0.300 |
Why?
|
| Retina | 1 | 2018 | 2616 | 0.300 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2011 | 339 | 0.290 |
Why?
|
| Megestrol Acetate | 1 | 2006 | 18 | 0.290 |
Why?
|
| Public Policy | 1 | 2011 | 572 | 0.290 |
Why?
|
| International Classification of Diseases | 1 | 2012 | 867 | 0.290 |
Why?
|
| Migraine with Aura | 1 | 2009 | 203 | 0.280 |
Why?
|
| Neurobiology | 1 | 2007 | 121 | 0.280 |
Why?
|
| Drug Prescriptions | 1 | 2016 | 1637 | 0.280 |
Why?
|
| Mental Competency | 1 | 2007 | 176 | 0.280 |
Why?
|
| Microcephaly | 1 | 2010 | 432 | 0.280 |
Why?
|
| World War I | 1 | 2006 | 13 | 0.280 |
Why?
|
| Aging | 5 | 2019 | 8664 | 0.280 |
Why?
|
| Professional Practice Location | 1 | 2006 | 59 | 0.280 |
Why?
|
| Poetry as Topic | 1 | 2006 | 17 | 0.280 |
Why?
|
| Neuromuscular Diseases | 1 | 2009 | 248 | 0.280 |
Why?
|
| Imagination | 1 | 2007 | 221 | 0.280 |
Why?
|
| Cross-Sectional Studies | 12 | 2023 | 25043 | 0.270 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2011 | 738 | 0.270 |
Why?
|
| Neurocysticercosis | 2 | 2017 | 62 | 0.270 |
Why?
|
| Steroids | 1 | 2011 | 930 | 0.270 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2012 | 810 | 0.270 |
Why?
|
| Poverty Areas | 1 | 2007 | 275 | 0.270 |
Why?
|
| Chloroquine | 1 | 2007 | 280 | 0.270 |
Why?
|
| Medicine in Literature | 1 | 2006 | 31 | 0.270 |
Why?
|
| Cohort Studies | 13 | 2021 | 40561 | 0.270 |
Why?
|
| Carcinoma, Small Cell | 1 | 2008 | 420 | 0.270 |
Why?
|
| Nucleus Accumbens | 1 | 2008 | 366 | 0.270 |
Why?
|
| Africa South of the Sahara | 2 | 2021 | 724 | 0.270 |
Why?
|
| Risk Factors | 16 | 2019 | 72290 | 0.270 |
Why?
|
| Anorexia | 1 | 2006 | 161 | 0.270 |
Why?
|
| Tomography, Optical Coherence | 1 | 2018 | 2657 | 0.270 |
Why?
|
| Visitors to Patients | 1 | 2005 | 35 | 0.270 |
Why?
|
| Arm | 1 | 2009 | 589 | 0.260 |
Why?
|
| Emigrants and Immigrants | 1 | 2012 | 522 | 0.260 |
Why?
|
| Myasthenia Gravis | 1 | 2008 | 199 | 0.260 |
Why?
|
| Immunocompromised Host | 2 | 2021 | 847 | 0.260 |
Why?
|
| Students, Medical | 3 | 2008 | 1862 | 0.260 |
Why?
|
| Retinal Vessels | 1 | 2010 | 772 | 0.250 |
Why?
|
| Cerebral Arteries | 1 | 2007 | 494 | 0.250 |
Why?
|
| Philosophy, Medical | 1 | 2005 | 79 | 0.250 |
Why?
|
| Pulmonary Edema | 1 | 2008 | 414 | 0.250 |
Why?
|
| Cerebrovascular Disorders | 2 | 2012 | 1504 | 0.250 |
Why?
|
| Disability Evaluation | 4 | 2024 | 1827 | 0.250 |
Why?
|
| Anti-Bacterial Agents | 3 | 2021 | 7181 | 0.250 |
Why?
|
| Severity of Illness Index | 5 | 2021 | 15540 | 0.250 |
Why?
|
| Telemedicine | 3 | 2021 | 2872 | 0.240 |
Why?
|
| Employee Performance Appraisal | 1 | 2004 | 87 | 0.240 |
Why?
|
| Developed Countries | 2 | 2019 | 437 | 0.240 |
Why?
|
| Retinal Diseases | 1 | 2010 | 683 | 0.240 |
Why?
|
| Public Health | 3 | 2023 | 2603 | 0.240 |
Why?
|
| Pandemics | 3 | 2021 | 8388 | 0.240 |
Why?
|
| Cultural Diversity | 1 | 2007 | 359 | 0.240 |
Why?
|
| Follow-Up Studies | 9 | 2021 | 39050 | 0.240 |
Why?
|
| Wit and Humor as Topic | 1 | 2003 | 31 | 0.230 |
Why?
|
| Military Medicine | 1 | 2006 | 176 | 0.230 |
Why?
|
| Hospitals | 3 | 2018 | 3952 | 0.230 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2011 | 1354 | 0.230 |
Why?
|
| Self-Help Groups | 1 | 2005 | 190 | 0.230 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2012 | 2232 | 0.230 |
Why?
|
| Hydroxychloroquine | 1 | 2007 | 412 | 0.230 |
Why?
|
| Deglutition Disorders | 2 | 2019 | 605 | 0.230 |
Why?
|
| Family Practice | 1 | 2006 | 516 | 0.230 |
Why?
|
| Psychotic Disorders | 2 | 2008 | 3046 | 0.230 |
Why?
|
| Physical Fitness | 1 | 2008 | 733 | 0.230 |
Why?
|
| Attitude of Health Personnel | 2 | 2015 | 3843 | 0.220 |
Why?
|
| Muscular Diseases | 1 | 2007 | 556 | 0.220 |
Why?
|
| Rural Health Services | 1 | 2006 | 379 | 0.220 |
Why?
|
| Mood Disorders | 1 | 2009 | 1106 | 0.210 |
Why?
|
| Automobile Driving | 1 | 2007 | 431 | 0.210 |
Why?
|
| Quality of Health Care | 1 | 2018 | 4371 | 0.210 |
Why?
|
| Time Factors | 8 | 2021 | 40075 | 0.210 |
Why?
|
| Anti-HIV Agents | 2 | 2015 | 4256 | 0.210 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3133 | 0.210 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3240 | 0.210 |
Why?
|
| Colchicine | 1 | 2023 | 243 | 0.210 |
Why?
|
| Sex Factors | 5 | 2020 | 10397 | 0.210 |
Why?
|
| Poliomyelitis | 2 | 2013 | 103 | 0.210 |
Why?
|
| Body Weight | 2 | 2018 | 4669 | 0.200 |
Why?
|
| Physicians | 3 | 2011 | 4567 | 0.200 |
Why?
|
| Seizures, Febrile | 1 | 2023 | 111 | 0.200 |
Why?
|
| Axons | 1 | 2010 | 1684 | 0.200 |
Why?
|
| Phosphoproteins | 1 | 2010 | 2440 | 0.200 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2010 | 2737 | 0.200 |
Why?
|
| Private Sector | 2 | 2015 | 392 | 0.200 |
Why?
|
| Comorbidity | 4 | 2019 | 10388 | 0.200 |
Why?
|
| Disease Progression | 5 | 2024 | 13284 | 0.200 |
Why?
|
| Organizations | 1 | 2022 | 170 | 0.200 |
Why?
|
| Heart Arrest | 1 | 2011 | 1470 | 0.200 |
Why?
|
| Mali | 1 | 2021 | 44 | 0.200 |
Why?
|
| Vaccination | 3 | 2022 | 3278 | 0.190 |
Why?
|
| Lung Transplantation | 1 | 2010 | 1153 | 0.190 |
Why?
|
| Niger | 1 | 2021 | 39 | 0.190 |
Why?
|
| Encephalomyelitis, Eastern Equine | 1 | 2020 | 15 | 0.190 |
Why?
|
| Community Health Planning | 2 | 2012 | 165 | 0.190 |
Why?
|
| Burkina Faso | 1 | 2021 | 88 | 0.190 |
Why?
|
| Healthcare Disparities | 3 | 2017 | 3158 | 0.190 |
Why?
|
| Schizophrenic Psychology | 1 | 2008 | 1678 | 0.190 |
Why?
|
| United States | 11 | 2023 | 69872 | 0.190 |
Why?
|
| Neisseria meningitidis | 1 | 2021 | 109 | 0.190 |
Why?
|
| Burnout, Professional | 1 | 2009 | 694 | 0.190 |
Why?
|
| Haemophilus influenzae | 1 | 2021 | 171 | 0.190 |
Why?
|
| Salmonella | 1 | 2021 | 129 | 0.190 |
Why?
|
| Spinal Puncture | 2 | 2015 | 281 | 0.180 |
Why?
|
| Diabetes Complications | 1 | 2007 | 1359 | 0.180 |
Why?
|
| Body Mass Index | 1 | 2018 | 12720 | 0.180 |
Why?
|
| Diagnosis, Differential | 7 | 2015 | 12959 | 0.180 |
Why?
|
| Urban Population | 3 | 2022 | 2021 | 0.180 |
Why?
|
| Cryptococcus neoformans | 1 | 2021 | 119 | 0.180 |
Why?
|
| Cognition | 3 | 2018 | 6770 | 0.180 |
Why?
|
| Interpersonal Relations | 1 | 2007 | 1425 | 0.180 |
Why?
|
| Acyclovir | 2 | 2013 | 272 | 0.180 |
Why?
|
| Age Factors | 8 | 2019 | 18370 | 0.180 |
Why?
|
| Apolipoproteins | 1 | 2022 | 317 | 0.180 |
Why?
|
| HIV-1 | 1 | 2018 | 6939 | 0.180 |
Why?
|
| Hypertension | 4 | 2019 | 8480 | 0.180 |
Why?
|
| Japan | 2 | 2016 | 1360 | 0.180 |
Why?
|
| Bangladesh | 2 | 2012 | 687 | 0.180 |
Why?
|
| Recurrence | 6 | 2023 | 8340 | 0.180 |
Why?
|
| Survivors | 1 | 2010 | 2291 | 0.180 |
Why?
|
| Electronics | 1 | 2021 | 322 | 0.180 |
Why?
|
| Multivariate Analysis | 3 | 2020 | 12245 | 0.180 |
Why?
|
| Corpus Callosum | 2 | 2016 | 737 | 0.180 |
Why?
|
| Cadmium | 1 | 2020 | 212 | 0.170 |
Why?
|
| Schizophrenia | 2 | 2008 | 6882 | 0.170 |
Why?
|
| Lebanon | 1 | 2020 | 229 | 0.170 |
Why?
|
| Immunoglobulins, Intravenous | 2 | 2021 | 652 | 0.170 |
Why?
|
| Mental Health | 3 | 2021 | 3019 | 0.170 |
Why?
|
| Medicine, African Traditional | 1 | 2019 | 29 | 0.170 |
Why?
|
| Valine | 2 | 2013 | 413 | 0.170 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2024 | 9959 | 0.170 |
Why?
|
| Health Care Costs | 4 | 2020 | 3209 | 0.170 |
Why?
|
| China | 2 | 2016 | 2248 | 0.170 |
Why?
|
| Infant | 8 | 2019 | 35136 | 0.170 |
Why?
|
| Critical Care | 1 | 2011 | 2647 | 0.170 |
Why?
|
| Wechsler Scales | 1 | 2019 | 260 | 0.170 |
Why?
|
| Health Status | 1 | 2012 | 4034 | 0.160 |
Why?
|
| Chad | 1 | 2018 | 8 | 0.160 |
Why?
|
| Attitude to Health | 1 | 2007 | 2052 | 0.160 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2021 | 503 | 0.160 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2015 | 2559 | 0.160 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2009 | 3068 | 0.160 |
Why?
|
| Ebolavirus | 1 | 2021 | 263 | 0.160 |
Why?
|
| Nigeria | 1 | 2021 | 733 | 0.160 |
Why?
|
| Ocular Motility Disorders | 2 | 2009 | 135 | 0.150 |
Why?
|
| RNA, Neoplasm | 1 | 2020 | 769 | 0.150 |
Why?
|
| Prospective Studies | 8 | 2021 | 53288 | 0.150 |
Why?
|
| Drug Substitution | 1 | 2020 | 281 | 0.150 |
Why?
|
| Midwestern United States | 1 | 2017 | 70 | 0.150 |
Why?
|
| Arizona | 1 | 2017 | 108 | 0.150 |
Why?
|
| Air Pollution | 1 | 2011 | 2286 | 0.150 |
Why?
|
| Blood Platelets | 3 | 2022 | 2508 | 0.150 |
Why?
|
| Age of Onset | 2 | 2016 | 3271 | 0.150 |
Why?
|
| Psychiatry | 1 | 2009 | 1695 | 0.140 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2017 | 162 | 0.140 |
Why?
|
| Psychosocial Deprivation | 1 | 2017 | 99 | 0.140 |
Why?
|
| Logistic Models | 4 | 2020 | 13408 | 0.140 |
Why?
|
| Herpesvirus 3, Human | 1 | 2018 | 204 | 0.140 |
Why?
|
| Migraine Disorders | 1 | 2009 | 1620 | 0.140 |
Why?
|
| Peripartum Period | 1 | 2017 | 133 | 0.140 |
Why?
|
| Data Collection | 3 | 2013 | 3341 | 0.140 |
Why?
|
| Sensitivity and Specificity | 5 | 2019 | 14722 | 0.140 |
Why?
|
| Sodium | 1 | 2021 | 1623 | 0.140 |
Why?
|
| Policy Making | 1 | 2020 | 554 | 0.140 |
Why?
|
| Singapore | 1 | 2016 | 295 | 0.140 |
Why?
|
| India | 2 | 2013 | 2197 | 0.130 |
Why?
|
| Kenya | 1 | 2018 | 685 | 0.130 |
Why?
|
| Age Distribution | 2 | 2012 | 2902 | 0.130 |
Why?
|
| PubMed | 2 | 2017 | 123 | 0.130 |
Why?
|
| Phenytoin | 1 | 2016 | 197 | 0.130 |
Why?
|
| Heart Transplantation | 1 | 2009 | 3110 | 0.130 |
Why?
|
| Carbamazepine | 1 | 2016 | 229 | 0.130 |
Why?
|
| Streptococcus pneumoniae | 1 | 2021 | 714 | 0.130 |
Why?
|
| Patient Care | 2 | 2014 | 640 | 0.130 |
Why?
|
| Activities of Daily Living | 2 | 2019 | 2418 | 0.130 |
Why?
|
| Antiretroviral Therapy, Highly Active | 2 | 2015 | 1873 | 0.130 |
Why?
|
| Family Characteristics | 1 | 2020 | 1000 | 0.130 |
Why?
|
| Nervous System Malformations | 1 | 2017 | 247 | 0.130 |
Why?
|
| Dementia | 1 | 2009 | 2518 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2015 | 20129 | 0.130 |
Why?
|
| Photography | 1 | 2018 | 520 | 0.130 |
Why?
|
| Lung Neoplasms | 2 | 2010 | 13102 | 0.120 |
Why?
|
| Endothelial Cells | 1 | 2007 | 3479 | 0.120 |
Why?
|
| Fellowships and Scholarships | 1 | 2023 | 1076 | 0.120 |
Why?
|
| Substance-Related Disorders | 1 | 2010 | 4258 | 0.120 |
Why?
|
| Alzheimer Disease | 2 | 2014 | 8037 | 0.120 |
Why?
|
| Indonesia | 1 | 2014 | 119 | 0.120 |
Why?
|
| Asia, Western | 1 | 2013 | 20 | 0.120 |
Why?
|
| Contraception | 1 | 2017 | 359 | 0.120 |
Why?
|
| Public Sector | 1 | 2015 | 265 | 0.120 |
Why?
|
| Anxiety | 3 | 2023 | 4297 | 0.120 |
Why?
|
| Vasculitis | 1 | 2018 | 519 | 0.120 |
Why?
|
| Schools | 2 | 2019 | 1433 | 0.120 |
Why?
|
| Prevalence | 3 | 2020 | 15226 | 0.110 |
Why?
|
| Valproic Acid | 1 | 2016 | 445 | 0.110 |
Why?
|
| Rabies | 1 | 2013 | 61 | 0.110 |
Why?
|
| Socioeconomic Factors | 3 | 2017 | 7785 | 0.110 |
Why?
|
| Health Surveys | 3 | 2019 | 4037 | 0.110 |
Why?
|
| South Africa | 4 | 2019 | 1731 | 0.110 |
Why?
|
| Financial Support | 1 | 2013 | 115 | 0.110 |
Why?
|
| Neuropsychological Tests | 3 | 2011 | 6993 | 0.110 |
Why?
|
| Melkersson-Rosenthal Syndrome | 1 | 2012 | 3 | 0.110 |
Why?
|
| Government Agencies | 1 | 2013 | 156 | 0.110 |
Why?
|
| Disaster Medicine | 1 | 2013 | 75 | 0.110 |
Why?
|
| Monitoring, Physiologic | 1 | 2020 | 1738 | 0.110 |
Why?
|
| Poliovirus Vaccine, Inactivated | 1 | 2012 | 24 | 0.110 |
Why?
|
| Incidence | 3 | 2016 | 20947 | 0.110 |
Why?
|
| Baltimore | 1 | 2013 | 231 | 0.110 |
Why?
|
| HEK293 Cells | 1 | 2022 | 4204 | 0.110 |
Why?
|
| Head | 1 | 2018 | 880 | 0.110 |
Why?
|
| Cerebrospinal Fluid | 1 | 2015 | 534 | 0.110 |
Why?
|
| Public-Private Sector Partnerships | 1 | 2013 | 121 | 0.110 |
Why?
|
| International Cooperation | 1 | 2019 | 1420 | 0.110 |
Why?
|
| Leprosy | 1 | 2012 | 124 | 0.100 |
Why?
|
| RNA | 1 | 2022 | 2749 | 0.100 |
Why?
|
| Environmental Exposure | 2 | 2020 | 4234 | 0.100 |
Why?
|
| Hepatitis C | 2 | 2015 | 1591 | 0.100 |
Why?
|
| Muscle, Skeletal | 1 | 2007 | 4931 | 0.100 |
Why?
|
| Poliovirus | 1 | 2012 | 109 | 0.100 |
Why?
|
| Immunosuppressive Agents | 2 | 2017 | 4149 | 0.100 |
Why?
|
| Syphilis | 1 | 2014 | 227 | 0.100 |
Why?
|
| Bradycardia | 2 | 2017 | 307 | 0.100 |
Why?
|
| Meningitis, Bacterial | 1 | 2013 | 218 | 0.100 |
Why?
|
| Brain Neoplasms | 2 | 2020 | 8863 | 0.100 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 1855 | 0.100 |
Why?
|
| Parkinson Disease | 1 | 2005 | 2775 | 0.100 |
Why?
|
| Torture | 1 | 2011 | 53 | 0.100 |
Why?
|
| Environmental Pollutants | 1 | 2020 | 1179 | 0.100 |
Why?
|
| Laos | 1 | 2011 | 29 | 0.100 |
Why?
|
| Toes | 1 | 2012 | 206 | 0.100 |
Why?
|
| Disease Outbreaks | 1 | 2021 | 1772 | 0.100 |
Why?
|
| Museums | 1 | 2010 | 19 | 0.100 |
Why?
|
| Employment | 1 | 2018 | 1132 | 0.100 |
Why?
|
| Postpartum Period | 1 | 2017 | 1086 | 0.100 |
Why?
|
| Immunization Schedule | 1 | 2012 | 221 | 0.100 |
Why?
|
| DNA-Binding Proteins | 1 | 2008 | 9648 | 0.100 |
Why?
|
| Social Conditions | 1 | 2011 | 126 | 0.100 |
Why?
|
| Meningitis | 1 | 2012 | 216 | 0.090 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 3176 | 0.090 |
Why?
|
| Social Work | 1 | 2012 | 162 | 0.090 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2015 | 525 | 0.090 |
Why?
|
| History, 20th Century | 2 | 2010 | 2740 | 0.090 |
Why?
|
| Educational Measurement | 2 | 2008 | 1210 | 0.090 |
Why?
|
| Plant Leaves | 1 | 2010 | 143 | 0.090 |
Why?
|
| Anxiety Disorders | 1 | 2021 | 2690 | 0.090 |
Why?
|
| Health Services Research | 1 | 2018 | 1836 | 0.090 |
Why?
|
| Prognosis | 3 | 2017 | 29063 | 0.090 |
Why?
|
| Specimen Handling | 1 | 2014 | 694 | 0.090 |
Why?
|
| Endocarditis | 1 | 2014 | 350 | 0.090 |
Why?
|
| Minnesota | 1 | 2010 | 344 | 0.090 |
Why?
|
| Evidence-Based Medicine | 2 | 2015 | 3610 | 0.090 |
Why?
|
| Apnea | 1 | 2011 | 195 | 0.090 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2012 | 6038 | 0.090 |
Why?
|
| Immunoglobulin G | 1 | 2021 | 4560 | 0.090 |
Why?
|
| Sexuality | 1 | 2011 | 174 | 0.090 |
Why?
|
| Herpes Simplex | 1 | 2013 | 470 | 0.090 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2008 | 5221 | 0.090 |
Why?
|
| Temporal Lobe | 1 | 2017 | 1670 | 0.090 |
Why?
|
| Gloves, Protective | 1 | 2008 | 22 | 0.080 |
Why?
|
| Hospital Mortality | 2 | 2014 | 5317 | 0.080 |
Why?
|
| Databases, Factual | 2 | 2016 | 7729 | 0.080 |
Why?
|
| Disabled Persons | 2 | 2011 | 1212 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 2 | 2012 | 5391 | 0.080 |
Why?
|
| Stem Cells | 1 | 2022 | 3567 | 0.080 |
Why?
|
| Brain Stem Infarctions | 1 | 2009 | 32 | 0.080 |
Why?
|
| Cartilage Diseases | 1 | 2010 | 160 | 0.080 |
Why?
|
| Movement Disorders | 1 | 2012 | 445 | 0.080 |
Why?
|
| Ventricular Fibrillation | 1 | 2011 | 538 | 0.080 |
Why?
|
| Thiamine | 1 | 2009 | 152 | 0.080 |
Why?
|
| Work Schedule Tolerance | 1 | 2013 | 565 | 0.080 |
Why?
|
| Uganda | 1 | 2013 | 1243 | 0.080 |
Why?
|
| Saskatchewan | 1 | 2007 | 9 | 0.080 |
Why?
|
| Antiviral Agents | 2 | 2013 | 2987 | 0.080 |
Why?
|
| History, 19th Century | 1 | 2010 | 720 | 0.080 |
Why?
|
| Electrodiagnosis | 1 | 2008 | 151 | 0.080 |
Why?
|
| Photophobia | 1 | 2008 | 67 | 0.080 |
Why?
|
| Community Networks | 1 | 2010 | 203 | 0.080 |
Why?
|
| Regression Analysis | 1 | 2018 | 6459 | 0.080 |
Why?
|
| Dyslipidemias | 1 | 2015 | 849 | 0.080 |
Why?
|
| Vertebral Artery | 1 | 2009 | 192 | 0.080 |
Why?
|
| Head Injuries, Closed | 1 | 2009 | 136 | 0.080 |
Why?
|
| Medically Underserved Area | 1 | 2010 | 253 | 0.080 |
Why?
|
| Pons | 1 | 2009 | 245 | 0.080 |
Why?
|
| Genotype | 1 | 2022 | 12951 | 0.080 |
Why?
|
| Paresis | 1 | 2009 | 179 | 0.080 |
Why?
|
| Infant, Newborn | 3 | 2012 | 25625 | 0.080 |
Why?
|
| Ataxia | 1 | 2009 | 304 | 0.080 |
Why?
|
| Vitamin B Complex | 1 | 2009 | 288 | 0.070 |
Why?
|
| Leg | 1 | 2012 | 1116 | 0.070 |
Why?
|
| Caregivers | 1 | 2019 | 2094 | 0.070 |
Why?
|
| Tongue Diseases | 1 | 2007 | 67 | 0.070 |
Why?
|
| Embolism | 1 | 2010 | 408 | 0.070 |
Why?
|
| Scleroderma, Localized | 1 | 2007 | 79 | 0.070 |
Why?
|
| Pregnancy Complications | 2 | 2017 | 2861 | 0.070 |
Why?
|
| Laryngeal Muscles | 1 | 2007 | 98 | 0.070 |
Why?
|
| Sex Distribution | 1 | 2012 | 2297 | 0.070 |
Why?
|
| Injections, Intravenous | 1 | 2009 | 1420 | 0.070 |
Why?
|
| Cerebral Infarction | 1 | 2011 | 1011 | 0.070 |
Why?
|
| Survival Rate | 2 | 2011 | 12788 | 0.070 |
Why?
|
| Fatal Outcome | 1 | 2011 | 1850 | 0.070 |
Why?
|
| Epidemics | 1 | 2012 | 523 | 0.070 |
Why?
|
| Spinal Cord Injuries | 1 | 2014 | 931 | 0.070 |
Why?
|
| Hospital Volunteers | 1 | 2005 | 6 | 0.070 |
Why?
|
| Publications | 1 | 2008 | 195 | 0.070 |
Why?
|
| Health Services | 1 | 2011 | 758 | 0.070 |
Why?
|
| Mental Processes | 1 | 2007 | 249 | 0.070 |
Why?
|
| Mutation | 1 | 2010 | 29786 | 0.070 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2008 | 253 | 0.070 |
Why?
|
| Blood-Brain Barrier | 1 | 2012 | 1017 | 0.070 |
Why?
|
| Confidence Intervals | 1 | 2011 | 2971 | 0.070 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2009 | 501 | 0.070 |
Why?
|
| Multicenter Studies as Topic | 1 | 2010 | 1677 | 0.070 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2017 | 1519 | 0.070 |
Why?
|
| Glioblastoma | 1 | 2020 | 3481 | 0.060 |
Why?
|
| Patient Selection | 1 | 2017 | 4215 | 0.060 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 2703 | 0.060 |
Why?
|
| Job Application | 1 | 2004 | 39 | 0.060 |
Why?
|
| Interviews as Topic | 1 | 2012 | 2539 | 0.060 |
Why?
|
| Risk | 2 | 2017 | 9687 | 0.060 |
Why?
|
| Pharynx | 1 | 2007 | 413 | 0.060 |
Why?
|
| Thalamus | 1 | 2010 | 1023 | 0.060 |
Why?
|
| Antitubercular Agents | 1 | 2012 | 1320 | 0.060 |
Why?
|
| Behavior | 1 | 2007 | 561 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2014 | 6171 | 0.060 |
Why?
|
| Memory Disorders | 1 | 2011 | 1184 | 0.060 |
Why?
|
| Tongue | 1 | 2007 | 406 | 0.060 |
Why?
|
| Cholesterol | 1 | 2013 | 2917 | 0.060 |
Why?
|
| Survival Analysis | 2 | 2020 | 10252 | 0.060 |
Why?
|
| Intensive Care Units | 2 | 2021 | 3679 | 0.060 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2009 | 1107 | 0.060 |
Why?
|
| Prejudice | 1 | 2008 | 570 | 0.060 |
Why?
|
| Safety | 1 | 2008 | 1186 | 0.060 |
Why?
|
| Longitudinal Studies | 3 | 2019 | 13989 | 0.060 |
Why?
|
| Early Diagnosis | 1 | 2009 | 1184 | 0.060 |
Why?
|
| Independent Living | 2 | 2018 | 568 | 0.060 |
Why?
|
| Viral Load | 1 | 2012 | 3299 | 0.060 |
Why?
|
| Ambulatory Care Facilities | 1 | 2010 | 933 | 0.060 |
Why?
|
| Models, Statistical | 2 | 2015 | 5102 | 0.060 |
Why?
|
| Hepatitis B | 1 | 2008 | 695 | 0.060 |
Why?
|
| Chronic Disease | 2 | 2023 | 9146 | 0.060 |
Why?
|
| Medicine | 1 | 2011 | 946 | 0.060 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2009 | 783 | 0.050 |
Why?
|
| Occupational Health | 1 | 2009 | 809 | 0.050 |
Why?
|
| Intermediate Filaments | 1 | 2023 | 175 | 0.050 |
Why?
|
| Positron-Emission Tomography | 2 | 2009 | 6234 | 0.050 |
Why?
|
| Anti-Retroviral Agents | 1 | 2012 | 1715 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2015 | 4386 | 0.050 |
Why?
|
| Aspirin | 2 | 2019 | 3282 | 0.050 |
Why?
|
| France | 1 | 2003 | 517 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 2716 | 0.050 |
Why?
|
| Attitude to Death | 1 | 2005 | 382 | 0.050 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2023 | 528 | 0.050 |
Why?
|
| Leukoencephalitis, Acute Hemorrhagic | 1 | 2021 | 16 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 19905 | 0.050 |
Why?
|
| Mental Recall | 1 | 2008 | 1205 | 0.050 |
Why?
|
| Personal Satisfaction | 1 | 2006 | 643 | 0.050 |
Why?
|
| Pain Measurement | 2 | 2012 | 3420 | 0.050 |
Why?
|
| Physician-Patient Relations | 2 | 2005 | 3229 | 0.050 |
Why?
|
| Research Design | 1 | 2017 | 5987 | 0.050 |
Why?
|
| Tuberculosis | 1 | 2014 | 1912 | 0.050 |
Why?
|
| Neurofilament Proteins | 1 | 2023 | 318 | 0.050 |
Why?
|
| Image Enhancement | 1 | 2012 | 2921 | 0.050 |
Why?
|
| Confusion | 1 | 2023 | 275 | 0.050 |
Why?
|
| Acute Disease | 2 | 2010 | 7149 | 0.050 |
Why?
|
| Counseling | 1 | 2008 | 1523 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2023 | 778 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2014 | 8949 | 0.040 |
Why?
|
| Culture | 1 | 2003 | 633 | 0.040 |
Why?
|
| Length of Stay | 1 | 2013 | 6309 | 0.040 |
Why?
|
| Internship and Residency | 2 | 2013 | 5788 | 0.040 |
Why?
|
| Immunization, Secondary | 1 | 2021 | 340 | 0.040 |
Why?
|
| Neural Pathways | 1 | 2010 | 2972 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2020 | 21746 | 0.040 |
Why?
|
| Antioxidants | 1 | 2007 | 1663 | 0.040 |
Why?
|
| Leukocytes | 1 | 2007 | 2043 | 0.040 |
Why?
|
| ROC Curve | 2 | 2020 | 3527 | 0.040 |
Why?
|
| Pregnancy | 2 | 2017 | 29144 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2007 | 1889 | 0.040 |
Why?
|
| Smoking | 1 | 2015 | 8987 | 0.040 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2006 | 1524 | 0.040 |
Why?
|
| Antirheumatic Agents | 1 | 2007 | 1339 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 15076 | 0.040 |
Why?
|
| Memory | 1 | 2007 | 2174 | 0.040 |
Why?
|
| Social Isolation | 1 | 2020 | 365 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2013 | 8554 | 0.040 |
Why?
|
| Pain | 1 | 2012 | 4986 | 0.040 |
Why?
|
| Acute Coronary Syndrome | 1 | 2010 | 2337 | 0.040 |
Why?
|
| Antibodies, Helminth | 1 | 2016 | 50 | 0.040 |
Why?
|
| Antigens, Helminth | 1 | 2016 | 64 | 0.040 |
Why?
|
| Taenia solium | 1 | 2016 | 21 | 0.040 |
Why?
|
| Sclerosis | 1 | 2017 | 213 | 0.040 |
Why?
|
| Transportation | 1 | 2018 | 214 | 0.030 |
Why?
|
| Skull | 1 | 2020 | 813 | 0.030 |
Why?
|
| Weight Gain | 1 | 2006 | 2292 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2020 | 907 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2016 | 23338 | 0.030 |
Why?
|
| Creatinine | 1 | 2020 | 1919 | 0.030 |
Why?
|
| Lactation | 1 | 2017 | 412 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2017 | 977 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2008 | 6442 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2021 | 2225 | 0.030 |
Why?
|
| Occupations | 1 | 2016 | 517 | 0.030 |
Why?
|
| Consensus | 1 | 2023 | 2959 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2017 | 1590 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2009 | 4599 | 0.030 |
Why?
|
| Thrombosis | 1 | 2007 | 2968 | 0.030 |
Why?
|
| Intracranial Hemorrhages | 1 | 2019 | 855 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2016 | 1682 | 0.030 |
Why?
|
| Publication Bias | 1 | 2013 | 162 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2021 | 2107 | 0.030 |
Why?
|
| Glasgow Coma Scale | 1 | 2013 | 570 | 0.030 |
Why?
|
| Palliative Care | 1 | 2006 | 3493 | 0.020 |
Why?
|
| Reflex, Abnormal | 1 | 2011 | 84 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2012 | 588 | 0.020 |
Why?
|
| Folic Acid | 1 | 2017 | 1300 | 0.020 |
Why?
|
| Disease Management | 1 | 2021 | 2459 | 0.020 |
Why?
|
| Granuloma | 1 | 2012 | 319 | 0.020 |
Why?
|
| Medical Futility | 1 | 2011 | 127 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 4851 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2023 | 8324 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 2214 | 0.020 |
Why?
|
| Life Support Care | 1 | 2011 | 228 | 0.020 |
Why?
|
| Antihypertensive Agents | 1 | 2019 | 2046 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2012 | 981 | 0.020 |
Why?
|
| Internet | 1 | 2021 | 3064 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 3870 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 13695 | 0.020 |
Why?
|
| Gadolinium DTPA | 1 | 2012 | 836 | 0.020 |
Why?
|
| Amnesia | 1 | 2010 | 248 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2022 | 3086 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 3586 | 0.020 |
Why?
|
| Overweight | 1 | 2019 | 2371 | 0.020 |
Why?
|
| Inflammation | 1 | 2007 | 10638 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2023 | 4687 | 0.020 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2010 | 271 | 0.020 |
Why?
|
| Linear Models | 1 | 2017 | 5952 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2013 | 1530 | 0.020 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2011 | 546 | 0.020 |
Why?
|
| Information Dissemination | 1 | 2014 | 1099 | 0.020 |
Why?
|
| Self Report | 1 | 2017 | 3558 | 0.020 |
Why?
|
| Syndrome | 1 | 2012 | 3251 | 0.020 |
Why?
|
| Brain Stem | 1 | 2011 | 846 | 0.020 |
Why?
|
| Health Status Disparities | 1 | 2017 | 1797 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 20822 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 4933 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2012 | 972 | 0.020 |
Why?
|
| Sleep | 1 | 2020 | 4623 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 3255 | 0.010 |
Why?
|
| Computational Biology | 1 | 2014 | 3521 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 2282 | 0.010 |
Why?
|
| Decision Support Techniques | 1 | 2011 | 1956 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2017 | 4468 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 5751 | 0.010 |
Why?
|
| Biopsy | 1 | 2012 | 6756 | 0.010 |
Why?
|
| Algorithms | 1 | 2020 | 13881 | 0.010 |
Why?
|
| Attention | 1 | 2010 | 2400 | 0.010 |
Why?
|
| Skin | 1 | 2012 | 4364 | 0.010 |
Why?
|
| Contrast Media | 1 | 2012 | 5300 | 0.010 |
Why?
|
| Bipolar Disorder | 1 | 2012 | 5027 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2010 | 6669 | 0.010 |
Why?
|
| Hospitalization | 1 | 2013 | 10262 | 0.010 |
Why?
|
| Animals | 1 | 2016 | 168757 | 0.000 |
Why?
|